Centene Corporation (CNC)
Can Centene Beat Q1 Earnings Estimates on Growing Premiums?
CNC's first-quarter results are likely to benefit from higher commercial marketplace memberships.
Exploring Analyst Estimates for Centene (CNC) Q1 Earnings, Beyond Revenue and EPS
Get a deeper insight into the potential performance of Centene (CNC) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Centene (CNC) Reports Next Week: Wall Street Expects Earnings Growth
Centene (CNC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene Extends SilverSummit's Presence to the Edges of Nevada
CNC's subsidiary, SilverSummit, secures a five-year Nevada Medicaid contract, reinforcing its foothold in managed care in rural and frontier areas.
3 Health Insurance Stocks Holding Green in Market Turmoil
During the recent market turmoil, three healthcare stocks have performed very well. Those stocks are deeply involved in the health insurance industry.
Strength Seen in Centene (CNC): Can Its 5.9% Jump Turn into More Strength?
Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Will Centene (CNC) Beat Estimates Again in Its Next Earnings Report?
Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 HMO Stocks to Watch Amid Nurse Shortages, High Tech Costs
The Medical-HMO industry rides on steady premium flows resulting from a growing customer base and contract wins. However, industry headwinds like elevated technology costs and workforce shortages remain concerns.
Centene & HMHB Hawaii Expand Partnership for Maternal Care
CNC's Ohana Health Plan and HMHB Hawaii expand maternal care, enhancing support for mothers and babies through strategic investment and community partnerships.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Centene: A Leader In Government-Sponsored Insurance And Its Prospects
Centene's business transformation and strategic focus on core segments have led to increased operational marginality, despite losing 3.3 million Medicaid customers in 2024. I assign a "Buy" rating to Centene, with a fair valuation of $73 per share, indicating a 27% potential increase from the current price. The company's competitive advantage lies in its focus on Medicaid and Medicare, but it faces risks from regulatory changes and strong competition.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
